
A blended research peptide combining CJC-1295 (no DAC) with Ipamorelin, studied for its synergistic effect on pulsatile growth hormone release without significantly elevating cortisol or prolactin.
By purchasing this product, you agree to our terms of service. This product is sold strictly for laboratory research purposes.
Typical research dosing is 100–300mcg per administration. Reconstitute with bacteriostatic water.